Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RECOVER
- Development stage
- Unknown
- Lead developer
- BOHECO
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
RECOVER is a topical pain relief spray developed by the Bombay Hemp Company (BOHECO). It is formulated with full-spectrum cannabis leaf extract, containing a range of cannabinoids including cannabidiol (CBD), along with terpenes, flavonoids, and phenols. The product is designed for instant relief from pain and inflammation by interacting with the body's endocannabinoid system, specifically targeting CB1 and CB2 receptors. It is marketed as a consumer wellness product rather than a pharmaceutical drug and is intended for topical application to affected areas.
- Brand names
- RECOVER
- Other names
- RECOVER Pain Relief SprayBOHECO RECOVER
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on RECOVER.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RECOVER.